SCHEMBL9690202

SCHEMBL9690202

Nc1nc(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1S

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.62
MTOR P42345 2/20 0.62
ALDH1A1 P00352 2/20 0.62
TP53 P04637 2/20 0.62
THRB P10828 1/20 0.62
MDM2 Q00987 1/20 0.62
NCOA1 Q15788 1/20 0.62
NCOA3 Q9Y6Q9 1/20 0.62
GMNN O75496 1/20 0.62
NFKB1 P19838 1/20 0.62
DNMT1 P26358 1/20 0.62
THPO P40225 1/20 0.62
HTT P42858 1/20 0.62
RAB9A P51151 1/20 0.62
BLM P54132 1/20 0.62
HBB P68871 1/20 0.62
PMP22 Q01453 1/20 0.62
MAPT P10636 2/20 0.52
CDA P32320 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9690215 1.00 LMNA (0.62) LMNAMTORALDH1A1TP53THRB
SCHEMBL1138566 0.87 LMNA (0.64) LMNAMTORALDH1A1TP53THRB
SCHEMBL1138565 0.87 LMNA (0.64) LMNAMTORALDH1A1TP53THRB
SCHEMBL1138717 0.86 LMNA (0.63) LMNAMTORALDH1A1TP53THRB
SCHEMBL1138719 0.86 LMNA (0.63) LMNAMTORALDH1A1TP53THRB
SCHEMBL18858919 0.85 LMNA (0.62) LMNAMTORALDH1A1TP53THRB
SCHEMBL2584289 0.85 LMNA (0.62) LMNAMTORALDH1A1TP53THRB
SCHEMBL6297856 0.85 LMNA (0.62) LMNAMTORALDH1A1TP53THRB
SCHEMBL21423108 0.85 LMNA (0.62) LMNAMTORALDH1A1TP53THRB
SCHEMBL5697581 0.85 LMNA (0.62) LMNAMTORALDH1A1TP53THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992003127-A1 COMPOSITIONS AND METHODS FOR TREATING HIV INFECTIONS RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK (US) 1992-03-05 WO claimed
CN-118019527-A Method for preparing lipid nanoparticle compositions 摩登纳特斯有限公司 2024-05-10 CN disclosed
CN-118019526-A Methods for preparing lipid nanoparticle compositions for delivery of payload molecules to airway epithelium 摩登纳特斯有限公司 2024-05-10 CN disclosed
CN-117642421-A Engineered immune cells specifically targeting mesothelin and uses thereof 武田药品工业株式会社 2024-03-01 CN disclosed
CN-117085047-A Optimized oncolytic viruses and uses thereof 萨特治疗学有限公司 2023-11-21 CN disclosed
CN-116348147-A Compositions for delivery of payload molecules to airway epithelium 摩登纳特斯有限公司 2023-06-27 CN disclosed
CN-109982708-B Optimized oncolytic viruses and uses thereof 萨特治疗学有限公司 2023-05-23 CN disclosed
CN-116133652-A Method for preparing lipid nanoparticles 摩登纳特斯有限公司 2023-05-16 CN disclosed
CN-114901822-A Compositions and methods for simultaneously modulating gene expression 维萨梅布有限公司 2022-08-12 CN disclosed
WO-1992003127-A1 COMPOSITIONS AND METHODS FOR TREATING HIV INFECTIONS RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK (US) 1992-03-05 WO disclosed